Wojciech Cytawa

Smoluchowskiego Str. 17
Gdansk, PM 80952, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Prognostic Role of 18F-FDG PET/CT in Oligometastatic Non-Small Cell Lung Cancer: Preliminary Results from Single Center.

Prognostic Role of 18F-FDG PET/CT in Oligometastatic Non-Small Cell Lung Cancer: Preliminary Results from Single Center.

Journal: Cancers

Published: April 22, 2026

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer - a case report and review of the literature.

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer - a case report and review of the literature.

Journal: Frontiers in oncology

Published: January 04, 2026

Non-invasive assessment of PD-L1 status and histology in non-small cell lung cancer using 18F-FDG PET/CT radiomics.

Non-invasive assessment of PD-L1 status and histology in non-small cell lung cancer using 18F-FDG PET/CT radiomics.

Journal: Journal of translational medicine

Published: November 05, 2025

Can Artificial Intelligence Help Us in the Evaluation of Coronary Artery Calcification Scores by Acting as a Prognosticator in Patients That Are Operated on Due to Non-Small Cell Lung Cancer? A Pivotal Study.

Can Artificial Intelligence Help Us in the Evaluation of Coronary Artery Calcification Scores by Acting as a Prognosticator in Patients That Are Operated on Due to Non-Small Cell Lung Cancer? A Pivotal Study.

Journal: Journal of clinical medicine

Published: September 25, 2024

Long-term Disease Control in Lung Adenocarcinoma with Recurrent Oligometastases: PET-guided Management.

Long-term Disease Control in Lung Adenocarcinoma with Recurrent Oligometastases: PET-guided Management.

Journal: Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Published: August 09, 2024

Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons.

Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons.

Journal: Cancers

Published: April 14, 2024

Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.

Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 02, 2023

Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens.

Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 17, 2021

Challenging Visualization of Sentinel Lymph Nodes in Upper Urinary Tract Urothelial Carcinoma.

Challenging Visualization of Sentinel Lymph Nodes in Upper Urinary Tract Urothelial Carcinoma.

Journal: Journal of clinical medicine

Published: September 12, 2021

Radionuclide-guided sentinel lymph node mapping in urachal cancer.

Radionuclide-guided sentinel lymph node mapping in urachal cancer.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: March 02, 2021

PSMA Theranostics: A "Must Have" in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature.

PSMA Theranostics: A "Must Have" in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature.

Journal: Clinical genitourinary cancer

Published: November 05, 2020

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 18, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026